| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 559.11B | 630.90B | 561.00B | 512.48B | 487.13B | 399.59B |
| Gross Profit | 44.49B | 51.84B | 46.27B | 44.03B | 39.23B | 29.11B |
| EBITDA | 16.11B | 22.01B | 18.86B | 20.15B | 18.54B | 10.95B |
| Net Income | 4.83B | 7.69B | 7.47B | 7.00B | 7.09B | 5.96B |
Balance Sheet | ||||||
| Total Assets | 305.80B | 349.55B | 310.02B | 291.70B | 269.43B | 241.96B |
| Cash, Cash Equivalents and Short-Term Investments | 44.46B | 44.93B | 44.42B | 39.92B | 32.99B | 33.44B |
| Total Debt | 109.17B | 126.80B | 115.31B | 118.29B | 107.39B | 94.26B |
| Total Liabilities | 207.33B | 240.04B | 209.96B | 200.68B | 184.33B | 160.30B |
| Stockholders Equity | 84.46B | 93.19B | 85.94B | 84.33B | 80.89B | 77.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.19B | 17.89B | 11.87B | -5.32B | -35.19B |
| Operating Cash Flow | 0.00 | -3.28B | 20.20B | 15.67B | -363.00M | -26.63B |
| Investing Cash Flow | 0.00 | -4.86B | 61.00M | -6.61B | -5.60B | -16.17B |
| Financing Cash Flow | 0.00 | 6.93B | -16.11B | -3.00B | 3.71B | 34.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥530.84B | 20.39 | ― | 1.02% | 32.81% | 59.74% | |
79 Outperform | ¥87.56B | 15.26 | 12.96% | 1.36% | 19.33% | 20.49% | |
71 Outperform | ¥172.73B | 12.30 | ― | 0.93% | 27.31% | 0.92% | |
70 Outperform | ¥95.16B | 14.87 | ― | 1.85% | 20.88% | 15.69% | |
63 Neutral | ¥104.64B | 9.61 | ― | 4.31% | 12.46% | 6.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥128.47B | -7.98 | ― | 2.45% | 1.60% | -74.21% |